FDA 483 - Octapharma Plasma Inc - December 11, 2025

Octapharma Plasma Inc, a plasmapheresis center in Santa Fe Springs, CA, was cited for deficiencies in its donor screening process. The firm's standard operating procedures for determining donor eligibility, specifically regarding blood pressure measurement, were found to be incomplete. Furthermore, staff were observed failing to adhere to proper blood pressure measurement techniques, potentially compromising the accuracy of donor eligibility assessments.